Brief: Amicus Therapeutics Receives Positive CHMP Opinion For Pombiliti
16/12/2022 13:58
Dec 16 (Reuters) - Amicus Therapeutics Inc FOLD.O :
* AMICUS THERAPEUTICS RECEIVES POSITIVE CHMP OPINION FOR
POMBILITI™ (CIPAGLUCOSIDASE ALFA) FOR LATE-ONSET POMPE DISEASE
Source text for Eikon: ID:nGNX6FC0rP
Further company coverage: FOLD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amicus Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Amicus Q4 revenue beats estimates